Iintlobo zeCanscer Breast and Subtypes
Abaninzi bethu bathambekele ukucinga ngomhlaza wesifuba njengesifo esisodwa, kodwa uphando luyaqhubeka lubonakalisa ngenye indlela. Ukongezelela kwiindidi ezahlukeneyo zomhlaza wesifuba, kukho iinxalenye zesifo esithile. Uhlobo kunye ne-subtype yesifo somhlaza wesifuba, esichazwe kwingxelo yezobuchopho emva kokuhlinzwa, inikeza iqela lokukhathalela umdlavuza ulwazi oluyidingayo ukuphuhlisa isicwangciso esilungele ukuphatha ngempumelelo uhlobo oluthile kunye ne-subtype yomhlaza wesifuba.
> Jonga i-anatomy yebele kunye nesisombululo somhlaza wesifuba ngesigaba.
Iintlobo zeCanscer Breast
Ukuba ugqirha ugxeka umdlavuza webele, kuyafaneleka ukuba ufunde iintlobo ezahlukileyo ngoku, ngoko unesizathu sokuqonda ukuba kufuneka ukuxilongwa kukunyaniseka.
I-Cancer Cancer: Uninzi lweengcingo zesifuba ziqala kwiidolo ezithwala ubisi, ukuncelisa, ukuxelisa.
I-Ductal In-Situ (i-DCIS) : Eli nqanaba 0 umdlavuza ukhona ngaphakathi kwendlela yokubeletha.
-
Kuthetha ukuthini Ukuba Ndinezibonda Zakho Kwi-Wall Post Afterward?
-
Ukuba Ubomi Bakho Bubomvu kwaye Bubuhlungu, Ngaba Ngaba I-Cancer okanye iMastitis?
Ayichange aphule eludongeni lomzila okanye afikelele kwimizimba yesifuba esalungekileyo. Nangona kungengobomi obungozi kule ngongoma, i-DCIS imele iphathwe ngenxa yokuba kukho ingozi yayo ekugqibeleni ibe ngumhlaza ongenayo. I-DCIS idla ngokuthathwa kwi- mammogram kwaye iphathwa ngokuphumelelayo nge- lumpectomy (ukugcinwa kokuhlinzwa kwebele) kulandelwa unyango lwe-radiation .
I-ductal carcinoma (i-IDC) edibeneyo , eyaziwa nangokungena ngaphakathi kwe-ductal carcinoma, iyona ifomu eqhelekileyo yomhlaza wesifuba. Ingxelo malunga neepesenti ezingama-80 zazo zonke iingxaki zomhlaza webele. I-IDC iqale ekuqaleni kwindlela yokuloba ubisi, iphuma ngaphandle kwodonga lwamathambo, kwaye isasazeka kwiisisu zeenxa zonke.
Ukhohlo olungaphendulwanga, i-IDC inokukwazi ukusasaza ngaphaya kwebele kwaye ihambe kwiimpawu ezikude. I-IDC inokufunyanwa ngexesha lokuhlolwa kwebele lweklinikhi , i- mammogram , i- MRI , kunye namaxesha athile ekuhlolweni kwebele. Unyango lunokubandakanya enye okanye ngaphezulu kwezonyango eziqhelekileyo ezifana nokuhlinzwa, i-radiation, i-chemotherapy, unyango olujoliswe kuyo, kunye neyeza le-hormone.
I-Lobular carcinoma in-situ (i-LCIS ) ichaza ukukhula okungavamile kweeseli kwiibhola zamabele lapho kubisiwe ubisi. Ngelixa i-LCIS ingaqhubeki ngokuqhubekayo kumdlavuza ongenawo umonakalo, i-lobular carcinoma in situ ithathwa njengengozi yokuphucula umdlavuza webele xa ibele. I-LCIS idlalwa rhoqo ngexesha le- biopsy eyenziwa kwenye imeko yesifuba . Ukunyanga ngokukhawulezileyo akusoloko kuyimfuneko, nangona ilandelayo imeko ikhuthazwa ngokusondeleyo. Abasetyhini abasengozini enkulu yokuphucula umhlaza wesibeleko banokukhetha ukuba omnye okanye amabini amabini asuswe ukunciphisa amathuba abo okuphuhlisa eso sifo.
I-lobular carcinoma i-Invasive (ILC) , yesibini uhlobo oluqhelekileyo lomhlaza wesifuba, i-akhawunti engama-8 ekhulwini lweengxube zomhlaza zesisu ezingenayo.
I-ILC ayinakukwazi ukubonisa njengento ehlukileyo. Unyango lunokuquka ukuhlinzwa, i-chemotherapy, i-radiation, kunye ne-hormone therapy.
Umhlaza webele we-inflammatory (IBC) ngumhlaza onobukrakra, uhlawulela ngaphantsi kwama-5 ekhulwini weengcingo zebele. Ngokuqhelekileyo ayifaki necala. Iifayile zomhlaza ze-IBC zingene ngaphakathi kwesikhumba sebele kwaye zivimbele izitya zalo zelphm. Iimpawu zibandakanya i-rash kunye nekhuni ekhuniweyo. Isifuba esithintekileyo singabonakala sibomvu, siguqule kwaye sifudumele kumgca. Kungenokwenzeka ukuba okokuqala kungafunyanwa kakubi njenge-mastitis, isifo sesifuba. Ngokuxhomekeke kwinqanaba lomhlaza ekuxilongweni, unyango lunokubandakanya ukuhlinzwa, i-chemotherapy, unyango lwe-hormone, kunye nokunyangwa kwamayeza.
Isifo sikaPaget sesibalo siba ngaphantsi kwama-3 ekhulwini weengcingo zebele. Iimpawu zingabandakanya ukukhutshwa kweentomba, ukuphuma kwintsholongwane, kunye neengqumbo, isikhumba esikhathekayo esifana ne-eczema, imeko yesikhumba. Umdlavuza wesifuba uvame ukufunyaniswa ngokuba wenza i-biopsy ye-ingono. Phantse iipesenti ezingama-50 zezigulane ezinesifo sePaget sesibambe isisu esinokuvalelwa kwibele ngexesha lokuhlolwa kwebele.
Utyando luya kuxhomekeka kwisigaba kunye nezinye izinto, kubandakanywa nokuba ngaba akukho isifo somhlaza esiswini kwi-Additius. Unyango lunokubandakanya ukuhlinzwa, i-chemotherapy, kunye ne-hormone therapy.
Iintlobo zeeNtsholongwane zeBestile ziquka
Nangona kungenakwenzeka ukuba uya kuthi ufumane esinye sezi zinto, ukuba ufunyanwe naso sonke, le mihlaza yesifo esincinci, esaziwayo kuncinci ifanelekile ukuba iyazi.
I-Medullary carcinoma ithathwa njenge-subtype ye-ductal carcinoma. Unesiphelo xa usithintekile; ayiziveki njengeqhekeza. Ngokuqhelekileyo kubonakala kwi-mammogram. Ezi zicubu azinqabile ukufumana i-hormone receptor . Izinyango zokwelapha zibandakanya utyando, i-radiation, kunye ne-chemotherapy.
I-carbulaoma ye-Tubular ikwaqwalaselwa njengengxowankulu ye-ductal carcinoma. Iiseli zaso zibonakala ngathi zibukeka zibukeka phantsi kwe-microscope. Ivakalelwa i-spongy kwi-touch. Inokufunyanwa ngexesha lokuhlolwa kwesifuba okanye i-mammogram. Ngokuqhelekileyo ayikho umhlaza onomdla, uyayiphendula kakuhle kwindlela yokwelashwa kwebele yomhlaza.
I-carcinoma enomdla ithathwa njengento engaqhelekanga yomdlavuza we-ductal carcinoma, apho iiseli "zihamba" emachibini e-mucin, isithako esiyinhloko se-mucus. Ukuxilongwa kuthatha amanyathelo athile, kubandakanya ukuhlolwa ngokomzimba, i-mammogram, i-ultrasound, i-MRI, kunye ne-biopsy. Utyando, kuxhomekeke kwisigaba, kunokubandakanya ukuhlinzwa, i-chemotherapy, i-radiation, kunye ne-hormone therapy.
Umdlavuza webele we-Metastatic ngumhlaza webele wesigaba se-IV oye wasasazeka kwezinye iindawo zomzimba, ezinokubandakanya, kodwa ezingaphelelanga, ingqondo, ithambo, isibindi kunye nemiphunga. Yonyango, kodwa ngelishwa ayinakunyanga. Ngaphantsi kwama-10 ekhulwini kulabo abasandul Uninzi lweengxube zebele zesifo sebele zivela emva kweenyanga okanye iminyaka emva kokufunyaniswa kwaye uphathwe ngumhlaza wesibele.
Unyango luqhubekayo, kunye neenjongo zokubonelela ngomgangatho kuphela, kodwa ubude bomsebenzi. Ukongeza kwindlela yokuphathwa ngonyango lwe-chemotherapy, i-radiation, kunye / okanye unyango lwe-hormone, abafazi kunye nabesilisa abanomdlavuza webele we-metastatic bangakhetha ukufumana ukuba bafanelekile ukuthatha inxaxheba kwizilingo zonyango olutsha.
Iingxenye eziphambili zeCanscer Breast
Ukumisela isahluko somhlaza wesisu kwenziwa ngexesha le-biopsy, eyenziwa ngumgulane wezilwanyana, ogqirha. I-pathologist iqinisekisa ubungqina bomhlaza kwaye iphinda ihlolisise izicubu ze-tumor zikhangele iimpawu ze-genetic ne-hormonal zesifo somhlaza.
Iintlobo zintathu eziphambili zomhlaza wesifuba ziquka:
I-Hormone-receptor-positive: Uninzi lwezigulane zomhlaza zesifuba zinalo mhlathi wesifo somhlaza; izicubu zabo zingakhuthazwa ukuba zikhule kwaye zisasaze nge-estrogen okanye i-progesterone . I-akhawunti ye-hormone receptor i-tumor ye-tumor ye-65% ukuya kwi-75 yee-tumors. Iphathwe ngezidakamizwa ezifana ne- tamoxifen , enokuthi ithathwe ngabafazi besandulela kunye nabasemva, okanye i-aromatase inhibitors enokuthi ithathwe kuphela zizigulane ezithumela i-post menopausal. Iimithi zokwelapha ze-hormonal zivimba umsebenzi we-estrogen ukunciphisa ithuba lokuba nomhlaza wesibeleko sebele.
I-H2-positive: Lezi zicubu zinokukhula kwe- epidermal 2 , eyona mfuzo ehambisa iprotein ye-receptor. Ngeli xesha lo myalezo uyimfuneko ekukhuleni okuqhelekileyo kweeseli zebele, ngokugqithiseleyo, i-receptor ye-HER2 ingabangela umhlaza okhula. I-Chemotherapy yonyango oluqhelekileyo.
I- triple-negative: Umhlaza wesibeleko wesifuba esinezintathu awunayo i-estrogen receptors, i-progesterone receptors, okanye i-HER2 receptors. I-triple-negative iyancipha ngakumbi kwaye ichaphazela malunga neepesenti ezili-15 zalabo abanomdlavuza wesibele. Ngenxa yokuba i-triple-negative ayinayo i-hormone kunye ne-HER2 receptors, ayiphenduli kwi-hormone therapy, kunye ne-chemotherapy yonyango elinconywayo.
ILizwi
Naluphi na uhlobo okanye i-subtype yesifo somhlaza wesifuba, ihlala ifunyenwe kakuhle kwaye iphathwe kwinqanaba eliphambili, ngaphambi kokuba lisasazeka kwaye xa isona siphumo esihle kakhulu. Khangela ugqirha wakho weentsapho okanye ugqirha wamazinyo ekuhloleni rhoqo ngonyaka okuquka ukuhlolwa kwebele. Funda ngembali yakho yentsapho yomhlaza wesifuba; ukuba kukho umhlaza wesibeleko kwintsapho yakho, ncokola nomboneleli wakho wenkathalo malunga nokuba ufuna ukuqala ukufumana imimmogram.
Ukuba akukho nentsapho yomdlavuza wesibeletho, khumbula ukuba ama-85 ekhulwini weengcambu zebele ezenzekayo kwabasetyhini abangenalo nentsapho yembali yesifo. Musa ukuyeka ukufumana izilwanyana eziqhelekileyo ukususela kwiminyaka engama-40.
Ndivuyayo ndiyenzile. Zimbini, izilwanyana zazifumana umhlaza ebusweni bam ngaphambi kokuba zivezwe ekuhlolweni kwebele, kwaye ngaphambi kokuba umhlaza wesifuba ufanele unyango lwe-chemotherapy.
> Imithombo:
> I-American Cancer Society. Iintlobo zeCanscer Breast. Ukuhlaziywa kweMpilo yokugqibela: 09/25/2014
Ukuhlaziywa kokugqibela: 05/04/2016.
> Cancer.Net. I-Cancer Breast-Options Treatment. Uvunywe yiBhodi yeCarcer.Net i-Editorial, 02/2016.